PAIONEER
DEAD

Serial Number

78506558

Owner

Paion Deutschland GmbH

Attorney

GARY D. KRUGMAN

Filing Date

Oct 27, 2004

Add to watchlist:

No watchlists yet
View on USPTO

PAIONEER Trademark

Serial Number: 78506558 • Registration: 3734289

PAIONEER is a trademark filed by Paion Deutschland GmbH on October 27, 2004. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Paion Deutschland GmbH (11 trademarks)

Martinstr. 10-12
52062 Aachen , DE

Entity Type: 99

PAION GmbH (4 trademarks)

Kaiserplatz 5
Stolberg 52222 , DE

Entity Type: 03

Trademark Details

Filing Date

October 27, 2004

Registration Date

January 5, 2010

Published for Opposition

July 15, 2008

Cancellation Date

August 12, 2016

Goods & Services

Educational services, namely, providing informational events in the nature of seminars and workshops in the fields of pharmacology, medical procedures, product research and development of medical devices and pharmaceutical preparations, none of the foregoing services offered to the agricultural industry, including biopharming

Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents; medical and clinical diagnostic reagents for clinical or medical laboratory use, none of the foregoing goods for use in the agricultural industry, including biopharming

Computerized database management, namely, editing, evaluating and processing data for third parties

Reagents for scientific or medical research use; diagnostic reagents for scientific or research use, biochemical reagents for scientific or medical research use; reagents for scientific or research use, none of the foregoing goods for use in the agricultural industry, including biopharming

Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; licensing of intellectual property; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; preparation of expert opinions in the field biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, product research and development of medical devices and pharmaceutical preparations, and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment. scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment, none of the foregoing services offered to the agricultural industry, including biopharming

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 12, 2016 C8..
REGISTERED-PRINCIPAL REGISTER
Jan 5, 2010 R.PR
ASSIGNED TO EXAMINER
Jan 4, 2010 DOCK
TTAB RELEASE CASE TO TRADEMARKS
Dec 1, 2009 TMBN
OPPOSITION TERMINATED NO. 999999
Dec 1, 2009 OP.T
OPPOSITION DISMISSED NO. 999999
Dec 1, 2009 OP.D
OPPOSITION INSTITUTED NO. 999999
Jan 15, 2009 OP.I
REG. CANCELLED - RESTORED TO PENDENCY
Nov 7, 2008 CRTP
ASSIGNED TO PETITION STAFF
Oct 31, 2008 APET
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Oct 10, 2008 RCII
REGISTERED-PRINCIPAL REGISTER
Sep 30, 2008 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 14, 2008 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 14, 2008 ETOF
PUBLISHED FOR OPPOSITION
Jul 15, 2008 PUBO
NOTICE OF PUBLICATION
Jun 25, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 6, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2008 CNSA
AMENDMENT FROM APPLICANT ENTERED
Jun 3, 2008 ACEC
EXAMINER'S AMENDMENT ENTERED
Jun 3, 2008 XAEC
ASSIGNED TO LIE
Jun 2, 2008 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 2, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 2, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 2, 2008 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 2, 2008 ZZZX
1(B) BASIS DELETED; NEW BASIS REQUESTED
Jun 2, 2008 ADBS
NOTICE OF ALLOWANCE CANCELLED
Jun 2, 2008 IUCN
SOU EXTENSION 4 GRANTED
Apr 18, 2008 EX4G
SOU EXTENSION 4 FILED
Apr 18, 2008 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 18, 2008 EEXT
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Apr 16, 2008 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Apr 16, 2008 PCBG
ASSIGNED TO PETITION STAFF
Apr 16, 2008 APET
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2008 CRFA
PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Apr 11, 2008 PDCB
PAPER RECEIVED
Apr 11, 2008 MAIL
SOU EXTENSION 3 GRANTED
Oct 22, 2007 EX3G
SOU EXTENSION 3 FILED
Oct 22, 2007 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 22, 2007 EEXT
SOU EXTENSION 2 GRANTED
Jul 27, 2007 EX2G
SOU EXTENSION 2 FILED
Apr 18, 2007 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 18, 2007 EEXT
SOU EXTENSION 1 GRANTED
Oct 11, 2006 EX1G
SOU EXTENSION 1 FILED
Oct 11, 2006 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 11, 2006 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 25, 2006 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 4, 2006 ETOP
AMENDMENT FROM APPLICANT ENTERED
Oct 25, 2005 ACEC
PAPER RECEIVED
Oct 25, 2005 MAIL
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 20, 2005 ETOF
PUBLISHED FOR OPPOSITION
Oct 4, 2005 PUBO
NOTICE OF PUBLICATION
Sep 14, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 12, 2005 PREV
ASSIGNED TO LIE
Aug 10, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 2, 2005 CNSA
AMENDMENT FROM APPLICANT ENTERED
Aug 2, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2005 CRFA
PAPER RECEIVED
Jul 27, 2005 MAIL
NON-FINAL ACTION E-MAILED
Jun 2, 2005 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2005 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2005 DOCK
NEW APPLICATION ENTERED
Nov 5, 2004 NWAP